Nicholas J. DeNovio

Mr. DeNovio’s experience includes representing:

• TechnipFMC in:
  • Selling its Measurement Solutions business, an industrial measurement and sensing equipment business, to One Equity Partners
  • Its spinoff into two publicly traded oil and gas industrial companies, TechnipFMC and Technip Energies 
• Bunge in its US$8 billion acquisition of Viterra, a Netherlands-based agribusiness solutions company
• Omnicom Group in multiple transactions, including:
  • Acquiring Flywheel Digital, Ascential’s digital commerce business
  • Selling SELLBYTEL, a Germany-based provider of outsourced customer relationship management services, to Webhelp
• Boston Scientific, a medical device manufacturer, in multiple transactions, including:
  • Its US$1.07 billion acquisition of the surgical business of Lumenis, a company that develops and commercializes energy-based medical solutions, from Baring Private Equity Asia
  • Selling its intrauterine health product portfolio to Minerva Surgical
  • Acquiring Vertiflex, a developer of minimally invasive solutions to treat lumbar spinal stenosis
• NVIDIA in multiple transactions, including acquiring:
  • Oski Technology, a formal verification service
  • DeepMap, a provider of high-definition maps for autonomous vehicles
• Advanced Micro Devices (AMD) in its US$35 billion acquisition of Xilinx, a company that designs, develops, and markets complete programmable logic solutions
• Viasat in its:
  • US$7.3 billion acquisition of Inmarsat, a UK-based operator of mobile telecommunications satellite networks
  • Acquisition of Rignet, a cybersecurity company 
• Multiple entities in deSPAC transactions, including:
  • Heramba LLC and Heramba GMBH
  • 10X Capital Venture Acquisition Corp II
  • Marti Technologies
  • GoGreen Investments
• Allergan in its US$40.5 billion sale of its Global Generic Pharmaceuticals Business to Teva Pharmaceuticals
• FMC Technologies in its US$13 billion merger of equals with Technip, via the EU cross-border merger regime
• Globe Specialty Metals in its US$3.1 billion merger of equals with Grupo FerroAtlantica to create a leading international silicon and specialty metals producer
• Sorin in its US$2.7 billion merger of equals with Cyberonics to create a new medical technology company
• Actavis in its US$8.5 billion acquisition of Warner-Chilcott, an Ireland-based pharmaceutical company focusing on women’s healthcare
• Actavis in its US$28 billion acquisition of Forest Laboratories, a specialty pharmaceutical company